China NMPA approves Sanofi & Regeneron’s Dupixent as an add-on maintenance treatment for adults with uncontrolled COPD: Paris Monday, September 30, 2024, 11:00 Hrs [IST] The Nat ...
Dupixent also had been cleared for use in COPD in the European Union in early July, also for patients with uncontrolled ...
The National Medical Products Administration approved Dupixent as an add-on maintenance treatment for adults with ...
AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, ...
Sanofi and Regeneron have announced that dupilumab has received FDA approval as an add-on maintenance treatment for adults ...
Barclays analyst Carter Gould maintained a Buy rating on Regeneron (REGN – Research Report) today and set a price target of $1,220.00.
Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...
Former PM Ehud Olmert confirms Israel's role in the 2008 killing of Hezbollah's Mughniyeh, breaking 16-year silence on covert Syria mission. The Mitvim Institute's 2024 Foreign Policy Index ...
Meta Fined $102M for Storing Facebook Passwords in Plain Text ...
The Greek discovery of Iceland more than one thousand years prior to the Vikings is supported by evidence published recently in The Housman Society Journal. Based on an essentially linguistic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback